Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2013Clinical EndocrinologyOpen Access

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDimitrios PanidisPhilipps University of MarburgΚΤΚωνσταντίνος ΤζιόμαλοςGeneral / Preventive / LipidsEPEfstathios PapadakisAristotle University of Thessaloniki

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Panidis et al. (2013) studied this question.

synapsesocial.com/papers/6a0e7de18561d4cf804c3da0https://doi.org/10.1111/cen.12305
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Harmonizing the Metabolic Syndrome2009 · 14,988 citations
  2. 2Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases2011 · 18 citations
  3. 3Orlistat accentuates the fat-induced fall in blood pressure in older adults2011 · 5 citations
  4. 4Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome2011 · 60 citations